Tuesday, February 16, 2021

Early step toward leukemia drug therapy

The team has discovered that for acute myeloid leukemia (AML) patients, there is a dopamine receptor pathway that becomes abnormally activated in the cancer stem cells. This inspired the clinical investigation of a dopamine receptor-inhibiting drug thioridazine as a new therapy for patients, and their focus on adult AML has revealed encouraging results.

from Top Health News -- ScienceDaily https://ift.tt/3diJoRt

No comments:

Post a Comment

Common plastic chemical linked to lifelong anxiety in new study

Exposure to a common plastic chemical before and shortly after birth may have lasting effects on behavior. Researchers found that male rats ...